American Diabetes Association

ADA: Pathway to Stop Diabetes

Program Summary

Pathway to Stop Diabetes is a bold, innovative initiative designed to radically transform diabetes research.  To accelerate the research needed to discover solutions and ultimately cure this deadly epidemic, the American Diabetes Association is launching a bold new initiative, Pathway to Stop Diabetes, to inspire a new generation of diabetes researchers. Pathway will provide crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground‐breaking discoveries in diabetes prevention, treatment and cures.

Pathway will consider applications directed toward topics relevant to the prevention, treatment and cure of all diabetes types (type 1, type 2 and gestational), diabetes‐related disease states (obesity, pre‐diabetes, and other insulin resistant states) and diabetes complications. The program intends to attract individuals with a broad range of expertise in various science and technology disciplines, including medicine, biology, chemistry, computing and engineering, to the field of diabetes research.

Eligibility

Institutions may nominate a maximum of one investigator per grant cycle. The nomination can be in either of the Pathway award types:

Nominees must have the appropriate full‐time position to be eligible for the award at the sponsoring institution (postdoctoral fellow for Initiator, independent faculty appointment for Accelerator). Nominees are required to devote at least 75% of their total time and effort to research during the funding period. 

Nominations for individuals proposing innovative and transformational basic, clinical, translational, epidemiological or health services research that is relevant to any type of diabetes, diabetes-related disease state or complication are welcomed. Nominations of candidates in diverse disciplines, from medicine, biology and chemistry to engineering, mathematics and physics, are encouraged.

Award Information

Pathway will provide the means to conduct transformative science, including:

Internal Selection Process

The UI Office of the Vice President for Research and the Carver College of Medicine have established an internal review procedure to select the UI nominee. Applications will be reviewed according to the sponsor's selection criteria. Consideration will also be given to UI institutional strengths and strategic directions. Potential applicants must submit, using the preselection link below, the following information:
  1. A two page CV; and
  2. A description of the proposed project. It should have the following elements:
The above materials must be submitted no later than 5:00 p.m. on Friday, June 21, 2013. The selected nominee will be asked to complete the full application package in accordance with the sponsor's deadline of Friday, August 16, 2013.

Proposal due for preselection06/21/2013 Not open for submission deadline passed
Date Due to Sponsor08/16/2013
Required LOI Due DateN/A
Non-Required LOI Due DateN/A
Email:angie-robertson@uiowa.edu
Phone:319-353-3619
Sponsor URL:http://www.diabetes.org/pathway/program/

Admin/Reviewer Login here first

Back to the WINS main page